Access cutting-edge adolescent obesity treatment through this clinical trial at a research site in Ammon. Study-provided care at no cost to qualified participants.
Access adolescent obesity specialists in Ammon at no cost
This study follows strict safety protocols and ethical guidelines
All study-related adolescent obesity treatment provided free
The goal of the study is to assess how tirzepatide impacts bodyweight and cardiovascular risk factors when used in conjunction with healthy nutrition and physical activity in adolescents with obesity and multiple weight related comorbidities. The study will last approximately 76 weeks and may include up to 23 visits. Participants who have completed the primary 72-week GPIX study and have been off treatment for no more than 12 weeks (including the 4-week safety follow-up period), will have the o
Sponsor: Eli Lilly and Company
Check if you qualify for this adolescent obesity clinical trial in Ammon, ID
If you're searching for adolescent obesity treatment options in Ammon, ID, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ammon research site is actively enrolling participants for this clinical trial. You'll receive care from experienced adolescent obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.